Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer’s disease
Authors:
- 1 May 2011
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 60 (6) , 930-936
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 64 references indexed in Scilit:
- Memantine Preferentially Blocks Extrasynaptic over Synaptic NMDA Receptor Currents in Hippocampal AutapsesThe Journal of Neuroscience, 2010
- Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic MiceThe American Journal of Pathology, 2010
- Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (Aβ) peptide in the human neuroblastoma cellsNeuroscience Letters, 2010
- Effects of memantine on soluble Aβ25-35-induced changes in peptidergic and glial cells in Alzheimer’s disease model rat brain regionsNeuroscience, 2009
- MemantineCNS Drugs, 2009
- Memantine lowers amyloid‐β peptide levels in neuronal cultures and in APP/PS1 transgenic miceJournal of Neuroscience Research, 2009
- Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's‐disease‐model transgenic mice shown as by micromagnetic resonance imagingJournal of Neuroscience Research, 2008
- Effects of Memantine on Neuronal Structure and Conditioned Fear in the Tg2576 Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2008
- Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three casesJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Elevated levels of Aβ1–40 and Aβ1–42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic miceNeuroscience Letters, 2002